Data updated: Mar 10, 2026
CYTOVENE
GANCICLOVIR SODIUM
Approved 1989-06-23
7
Indications
--
Phase 3 Trials
3
Priority Reviews
36
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1989-06-23
- Routes
- INJECTION, ORAL
- Dosage Forms
- INJECTABLE, CAPSULE
CYTOVENE Approval History
Loading approval history...
What CYTOVENE Treats
7 FDA approvalsOriginally approved for its first indication in 1989 . Covers 7 distinct patient populations.
- Other (7)
Other
(7 approvals)- • Approved indication (Jun 1989) Priority
- • Approved indication (May 1992)
- • Approved indication (Dec 1994) Priority
- • Approved indication (Oct 1995) Priority
- • Approved indication (Nov 1996)
- • Approved indication (Dec 1997)
- • Approved indication (Aug 2018)Label
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CYTOVENE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.